52 /100
HIGH RISK
Score updated Jul 14, 2026

QTTB — Q32 Bio Inc. Dilution Risk Tracker

Track QTTB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track QTTB — Get alerts when the score changes →

As of July 14, 2026, Q32 Bio Inc. (QTTB) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Q32 Bio Inc. has a market capitalization of $187.37M, 16.96M shares outstanding, 55 institutional holders tracked. Key dilution vectors include ATM program capacity of $75.00M, 1.03M outstanding warrants, approximately 10 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
65
📊 Float Risk
55
⚠️ Warrant Exposure
30
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
32%
🔁 Convertible Conversion 40%
• Significant convertible debt: 16% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise 33%
• Under 12 months cash (10mo)
• Active ATM program with $75M remaining capacity
📜 Warrant Exercise 15%
• Warrant overhang: 6.0% of shares outstanding
🔔 Track QTTB — Get forecast alerts →

💹 Market Data

Market Cap$187.37M
Shares Outstanding16.96M
Float9.06M
Cash$50.75M
Debt$13.65M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 24.2% shares (2026Q1 vs prior)
55 institutional holders · 10.02M shares
#1 ORBIMED ADVISORS LLC 2.25M shares
#2 Atlas Venture Life Science Advisors, LLC 2.09M shares
#3 Opaleye Management Inc. 1.47M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest677.0K
Days to Cover1.6
% of Float7.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Jul 02, 2026
4 INSIDER TRANSACTION Jun 16, 2026
4 INSIDER TRANSACTION Jun 16, 2026
4 INSIDER TRANSACTION Jun 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for QTTB Shareholders

Q32 Bio Inc. (QTTB) has a DilutionScore of 52/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

QTTB has an active ATM (at-the-market) program with $75.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. DilutionWatch tracks 1.0M outstanding warrants for QTTB. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for QTTB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for QTTB alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work → Warrants Explained →
Track QTTB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QTTB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for QTTB
📊 QTTB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 QTTB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.